Li Wende, Huang Peigen, Chen David J, Gerweck Leo E
Department of Radiation Oncology, Massachusetts General Hospital, Boston, USA; Guangdong Medical College, PR China.
Department of Radiation Oncology, Massachusetts General Hospital, Boston, USA.
Radiother Oncol. 2014 Oct;113(1):146-9. doi: 10.1016/j.radonc.2014.09.006. Epub 2014 Oct 2.
The causes of tumor response variation to radiation remain obscure, thus hampering the development of predictive assays and strategies to decrease resistance. The present study evaluates the impact of host tumor stromal elements and the in vivo environment on tumor cell kill, and relationship between tumor cell radiosensitivity and the tumor control dose.
Five endpoints were evaluated and compared in a radiosensitive DNA double-strand break repair-defective (DNA-PKcs(-/-)) tumor line, and its DNA-PKcs repair competent transfected counterpart. In vitro colony formation assays were performed on in vitro cultured cells, on cells obtained directly from tumors, and on cells irradiated in situ. Permanent local control was assessed by the TCD50 assay. Vascular effects were evaluated by functional vascular density assays.
The fraction of repair competent and repair deficient tumor cells surviving radiation did not substantially differ whether irradiated in vitro, i.e., in the absence of host stromal elements and factors, from the fraction of cells killed following in vivo irradiation. Additionally, the altered tumor cell sensitivity resulted in a proportional change in the dose required to achieve permanent local control. The estimated number of tumor cells per tumor, their cloning efficiency and radiosensitivity, all assessed by in vitro assays, were used to predict successfully, the measured tumor control doses.
The number of clonogens per tumor and their radiosensitivity govern the permanent local control dose.
肿瘤对放疗反应差异的原因仍不清楚,这阻碍了预测性检测方法和降低抗性策略的发展。本研究评估宿主肿瘤基质成分和体内环境对肿瘤细胞杀伤的影响,以及肿瘤细胞放射敏感性与肿瘤控制剂量之间的关系。
在一个放射敏感的DNA双链断裂修复缺陷(DNA-PKcs(-/-))肿瘤系及其转染了具有DNA-PKcs修复能力的对应物中,评估并比较了五个终点指标。对体外培养的细胞、直接从肿瘤获取的细胞以及原位照射的细胞进行了体外集落形成试验。通过TCD50试验评估永久性局部控制情况。通过功能性血管密度试验评估血管效应。
无论是在体外照射(即不存在宿主基质成分和因子的情况下),还是体内照射后,具有修复能力和缺乏修复能力的肿瘤细胞存活分数并无显著差异。此外,肿瘤细胞敏感性的改变导致实现永久性局部控制所需剂量成比例变化。通过体外试验评估的每个肿瘤中肿瘤细胞的估计数量、它们的克隆效率和放射敏感性,成功用于预测所测量的肿瘤控制剂量。
每个肿瘤中克隆原的数量及其放射敏感性决定了永久性局部控制剂量。